Timothy Davis

BMedSc MB BS W.Aust., DPhil Oxf., FRACP, MRCP(UK), Professor

  • The University of Western Australia (M704), 35 Stirling Highway,

    6009 Perth

    Australia

  • 0 Citations
  • 0 h-Index
20032020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Funding overview

NHMRC project grant funding since 1993, NHMRC Practitioner Fellowship, other competitive and industry funding

Previous positions

Head of Fremantle Unit, School of Medicine and Pharmacology 2011-2013

Teaching

Clinical medical students, postgraduate supervision

Roles and responsibilities

Co-Lead, Diabetes and Endocrinology Network, WA Health Department

Research interests

Diabetes, malaria

Research expertise keywords

  • Biostatistics and epidemiology
  • Diabetes
  • Endocrinology
  • General medicine
  • Mathematical modelling
  • Tropical and infectious diseases

Fingerprint Dive into the research topics where Timothy Davis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes

Libianto, R., Davis, T. M. E. & Ekinci, E. I., Feb 2020, In : The Medical journal of Australia. 212, 3, p. 133-139 7 p.

The University of Western Australia

Research output: Contribution to journalReview articleResearchpeer-review

  • Pharmacotherapy for the prevention of malaria in pregnant women: currently available drugs and challenges

    Moore, B. R. & Davis, T. M. E., 2 Nov 2018, In : Expert Opinion on Pharmacotherapy. 19, 16, p. 1779-1796 18 p.

    The University of Western Australia

    Research output: Contribution to journalReview articleResearchpeer-review

  • Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective

    Davis, T. M. E., 1 May 2017, In : Clinical Therapeutics. 39, 5, p. 1012-1025 14 p.

    The University of Western Australia

    Research output: Contribution to journalReview articleResearchpeer-review

  • Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children

    Moore, B. R., Davis, W. A., Clarke, P. M., Robinson, L. J., Laman, M. & Davis, T. M. E., 30 Oct 2017, In : Malaria Journal. 16, 1, 438.

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
  • Polymorphisms in Plasmodium falciparum chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine

    WWARN AL and ASAQ Molecular Marker Study Group, Ouédraogo, J-B., Piola, P., Rombo, L., Schramm, B., Somé, A. F., Thwing, J., Ursing, J., Zeynudin, A., Zongo, I., Plowe, C. V. & Sibley, C. H., 2014, In : American Journal of Tropical Medicine and Hygiene. 91, 4, p. 833-843 11 p.

    Charles Darwin University

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
    File